Emily Ivey
BS ’18, microbiology, University of Rochester
MS ’19, immunology, microbiology and virology, University of Rochester
Thesis Title
TBD
Publications
- Timilsina, U., Umthong, S., Ivey, E.B. et al. SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5. Nat Commun 13, 2935 (2022). https://doi.org/10.1038/s41467-022-30609-9
- Umthong S, Lynch B, Timilsina U, Waxman B, Ivey EB, Stavrou S. 2021. Elucidating the antiviral mechanism of different MARCH factors. mBio 12:e03264-20.
- Umthong S, Lynch B, Timilsina U, Waxman B, Ivey EB, Stavrou S. 2021. Elucidating the antiviral mechanism of different MARCH factors. mBio 12:e03264-20.
- Umthong, S., Lynch, B., Timilsina, U., Waxman, B., Ivey, E. B., & Stavrou, S. (2020). Elucidating the antiviral mechanism of different MARCH factors. bioRxiv, 2020.2012.2022.422953. doi:10.1101/2020.12.22.422953
Professional/Educational Meetings/Abstracts
- 2023, May 17th “LGALS3BP/90K Restricts SARS-CoV-2 Infection by Targeting the Spike Glycoprotein.” Witebsky Conference on Microbial Pathogenesis, University at Buffalo, Buffalo NY.
- 2022, July 16th “LGALS3BP/90K Restricts SARS-CoV-2 by Targeting the Spike Glycoprotein.” American Society of Virology Annual Meeting, University of Madison Wisconsin, Madison WI.
- Joshua Austin Acklin, Emily Ivey, Rachel Alter, Ingrid Joylyn Paredes, Lucky Tran. “A Rush to Reopen Could Undo New Yorkers’ Hard Work against COVID-19.” Scientific American. (July, 2020)
- Uddhav Timilsina, Supawadee Umthong, Emily B. Ivey, Spyridon Stavrou. (July 2021). “SERINC5 potently restricts SARS-CoV-2 entry and is counteracted by ORF7a” American Society for Virology Annual Meeting.
- Supawadee Umthong, Brian Lynch, Uddhav Timilsina, Brandon Waxman, Emily B. Ivey, Spyridon Stavrou. (May 2021). “Elucidating the role of MARCH family proteins on viral envelope glycoproteins” Cold Spring Harbor, Retrovirology.